Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1

Grady Wulff
February 23, 2023

View both parts of the latest episode of our Meet the Analyst series where our Market Analyst, Grady Wulff, sits down with Dr. Tara Speranza, Healthcare & Biotech Analyst at Bell Potter, to discuss her outlook on the stocks she covers, Orthocell (ASX:OCC), Microba Life Sciences (ASX:MAP), and Monash IVF Group (ASX:MVF).

Take a look at Dr. Tara’s journey, her approach to analysing a company, and the first stock to be discussed, Orthocell (ASX:OCC).

In this video, Dr. Tara discusses:
– (0:59) Becoming a Bell Potter Analyst
– (2:56) Approaches to analysing a company
– (7:18) Orthocell’s global 25-year exclusive agreement
– (7:53) Orthocell’s TGA approval for its Remplir device
– (8:44) Orthocell’s speculative buy rating

Note: This interview was filmed on 7 February 2023.

 

View Part 2 here.

Weekly Wrap 2 February

Grady Wulff
February 2, 2024

Morning Bell 2 February

Sam Kanaan
February 2, 2024

Morning Bell 1 February

Sam Kanaan
February 1, 2024

Morning Bell 31 January

Grady Wulff
January 31, 2024

Morning Bell 30 January

Grady Wulff
January 30, 2024

Morning Bell 29 January

Grady Wulff
January 29, 2024

Morning Bell 25 January

Sam Kanaan
January 25, 2024

Morning Bell 24 January

Grady Wulff
January 24, 2024

Morning Bell 23 January

Grady Wulff
January 23, 2024

Morning Bell 22 January

Grady Wulff
January 22, 2024

Weekly Wrap 19 January

Sophia Mavridis
January 19, 2024

Morning Bell 19 January

Sam Kanaan
January 19, 2024